Clinical Trials Directory

Trials / Conditions / Autoimmune Diseases of the Nervous System

Autoimmune Diseases of the Nervous System

18 registered clinical trials studyying Autoimmune Diseases of the Nervous System — 7 currently recruiting.

StatusTrialSponsorPhase
SuspendedIDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis
NCT06677710
Indapta Therapeutics, INC.Phase 1
RecruitingA Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-relat
NCT06626919
Arcellx, Inc.Phase 1
RecruitingJY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024
Tongji HospitalN/A
RecruitingBiomarkers in Autoimmune Disease of Nervous System
NCT06502015
Tongji Hospital—
RecruitingNon-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
NCT05834855
Amsterdam UMC, location VUmcPhase 3
CompletedUkulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
NCT05792176
University of Texas at AustinN/A
UnknownSensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination
NCT05414890
Beijing Tiantan Hospital—
RecruitingAcceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
NCT04786821
Sheffield Teaching Hospitals NHS Foundation TrustN/A
RecruitingPredictors and Prognostic Factors of Myasthenia Gravis Outcome
NCT05214612
Assiut University—
CompletedAerobic Exercise for Remyelination in Multiple Sclerosis
NCT04539002
Oregon Health and Science UniversityPhase 1 / Phase 2
CompletedHumoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab T
NCT04837651
Dragonfly Research, LLC—
UnknownPower Training in Older Multiple Sclerosis Patients
NCT04762342
University of AarhusN/A
RecruitingSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the N
NCT04561557
Tongji HospitalEARLY_Phase 1
TerminatedSafety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis
NCT03540485
Fundación Pública Andaluza para la gestión de la Investigación en SevillaPhase 1 / Phase 2
WithdrawnStudy to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients Wit
NCT01453764
Ageless Regenerative InstituteN/A
CompletedStudy of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
NCT01684761
Opexa Therapeutics, Inc.Phase 2
CompletedAutologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosi
NCT01056471
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y SaludPhase 1 / Phase 2
CompletedA Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
NCT00304291
State University of New York at BuffaloPhase 4